Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Analysts Estimate J&J Snack Foods (JJSF) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate J&J Snack Foods (JJSF) to Report a Decline in Earnings: What to Look Out for

The market expects J&J Snack Foods (JJSF) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy?
Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when Jazz Pharmaceuticals (JAZZ) reports results for the quarter ended March 2025. While this widely-known consensus

Earnings Preview: IPG Photonics (IPGP) Q1 Earnings Expected to Decline
Earnings Preview: IPG Photonics (IPGP) Q1 Earnings Expected to Decline

Wall Street expects a year-over-year decline in earnings on lower revenues when IPG Photonics (IPGP) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

Ingredion (INGR) Earnings Expected to Grow: Should You Buy?
Ingredion (INGR) Earnings Expected to Grow: Should You Buy?

The market expects Ingredion (INGR) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook

Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Heron Therapeutics (HRTX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Intapp (INTA) Earnings Expected to Grow: Should You Buy?
Intapp (INTA) Earnings Expected to Grow: Should You Buy?

The market expects Intapp (INTA) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is

Analysts Estimate International General Insurance Holdings Ltd. (IGIC) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate International General Insurance Holdings Ltd. (IGIC) to Report a Decline in Earnings: What to Look Out for

Wall Street expects a year-over-year decline in earnings on higher revenues when International General Insurance Holdings Ltd. (IGIC) reports results for the quarter ended March 2025. While this

Will Forge Global Holdings, Inc. (FRGE) Report Negative Q1 Earnings? What You Should Know
Will Forge Global Holdings, Inc. (FRGE) Report Negative Q1 Earnings? What You Should Know

Forge Global Holdings, Inc. (FRGE) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known

Forrester Research (FORR) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Forrester Research (FORR) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Wall Street expects a year-over-year decline in earnings on lower revenues when Forrester Research (FORR) reports results for the quarter ended March 2025. While this widely-known consensus outlook

Will Genius Sports Limited (GENI) Report Negative Earnings Next Week? What You Should Know
Will Genius Sports Limited (GENI) Report Negative Earnings Next Week? What You Should Know

Genius Sports Limited (GENI) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Analysts Estimate Helios Technologies (HLIO) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Helios Technologies (HLIO) to Report a Decline in Earnings: What to Look Out for

Wall Street expects a year-over-year decline in earnings on lower revenues when Helios Technologies (HLIO) reports results for the quarter ended March 2025. While this widely-known consensus outlook

Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?
Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when Halozyme Therapeutics (HALO) reports results for the quarter ended March 2025. While this widely-known consensus

Enlight Renewable Energy Ltd. (ENLT) Earnings Expected to Grow: Should You Buy?
Enlight Renewable Energy Ltd. (ENLT) Earnings Expected to Grow: Should You Buy?

The market expects Enlight Renewable Energy Ltd. (ENLT) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This

Expeditors International (EXPD) Earnings Expected to Grow: Should You Buy?
Expeditors International (EXPD) Earnings Expected to Grow: Should You Buy?

The market expects Expeditors International (EXPD) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known

Earnings Preview: Fortune Brands Innovations (FBIN) Q1 Earnings Expected to Decline
Earnings Preview: Fortune Brands Innovations (FBIN) Q1 Earnings Expected to Decline

The market expects Fortune Brands Innovations (FBIN) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known

Analysts Estimate Datadog (DDOG) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Datadog (DDOG) to Report a Decline in Earnings: What to Look Out for

The market expects Datadog (DDOG) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is

Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for

The market expects Esperion Therapeutics (ESPR) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known

Coty (COTY) Reports Next Week: What You Should Expect
Coty (COTY) Reports Next Week: What You Should Expect

Coty (COTY) is expected to deliver flat earnings compared to the year-ago quarter on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook

Will Caribou Biosciences, Inc. (CRBU) Report Negative Q1 Earnings? What You Should Know
Will Caribou Biosciences, Inc. (CRBU) Report Negative Q1 Earnings? What You Should Know

The market expects Caribou Biosciences, Inc. (CRBU) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known

Coupang, Inc. (CPNG) Earnings Expected to Grow: Should You Buy?
Coupang, Inc. (CPNG) Earnings Expected to Grow: Should You Buy?

The market expects Coupang, Inc. (CPNG) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Corpay (CPAY) Earnings Expected to Grow: Should You Buy?
Corpay (CPAY) Earnings Expected to Grow: Should You Buy?

The market expects Corpay (CPAY) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is

Earnings Preview: Carlyle Secured Lending, Inc. (CGBD) Q1 Earnings Expected to Decline
Earnings Preview: Carlyle Secured Lending, Inc. (CGBD) Q1 Earnings Expected to Decline

Carlyle Secured Lending, Inc. (CGBD) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known

Apellis Pharmaceuticals, Inc. (APLS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Apellis Pharmaceuticals, Inc. (APLS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

The market expects Apellis Pharmaceuticals, Inc. (APLS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This

Allegiant Travel (ALGT) Reports Next Week: Wall Street Expects Earnings Growth
Allegiant Travel (ALGT) Reports Next Week: Wall Street Expects Earnings Growth

Allegiant Travel (ALGT) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook

Colliers International (CIGI) Earnings Expected to Grow: Should You Buy?
Colliers International (CIGI) Earnings Expected to Grow: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when Colliers International (CIGI) reports results for the quarter ended March 2025. While this widely-known consensus